AI-Powered brain zaps aim to boost memory in Alzheimer's

NCT ID NCT07208734

ENROLLING_BY_INVITATION Symptom relief Sponsor: Xuanwu Hospital, Beijing Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a personalized brain stimulation device (tACS) for older adults with mild cognitive impairment or mild Alzheimer's. The device uses AI to tailor the stimulation based on each person's brain scans. About 460 participants will join to see if it safely improves memory and thinking.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: transcranial alternating current stimulation (tACS) device
What this could lead to: If it works, this could offer a personalized, non-drug way to ease memory and thinking problems in older adults with Alzheimer's.
What could go wrong: This is an early-stage study testing safety and effectiveness. The approach is complex and may not work for everyone. Results are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER'S DISEASE

Contacts and locations

Locations

Xuanwu Hospital, Capital Medical University, Beijing, Beijing 100053

Beijing, Beijing Municipality, 100053, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.